# OnCo record paper-augment-lenalidomide-rituximab-leonard-jco-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-augment-lenalidomide-rituximab-leonard-jco-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-augment-lenalidomide-rituximab-leonard-jco-2019" ;
  schema:name "AUGMENT: lenalidomide plus rituximab versus rituximab alone in relapsed indolent lymphoma"@en ;
  schema:description "Adding lenalidomide to rituximab more than doubled the time to progression in relapsed follicular and marginal zone lymphoma compared with rituximab alone, establishing a chemotherapy-free option for relapsed indolent lymphoma."@en ;
  schema:url <https://onco.cc/key-papers/paper-augment-lenalidomide-rituximab-leonard-jco-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.19.00010>, <https://pubmed.ncbi.nlm.nih.gov/30897038/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.19.00010> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Leonard JP, Trneny M, Izutsu K, et al." ;
  onco:cancers <https://onco.cc/cancers/marginal-zone-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/rituximab/> ;
  onco:trials <https://onco.cc/trials/augment/> ;
  onco:journals <https://onco.cc/journals/jco/> .